Avicanna Makes RHO Phyto™ Medical Cannabis Products Available In Canadian Hospital Pharmacies Through Agreement with Sunnybrook Hospital
May 06, 2021 07:30 ET | Source: Avicanna Inc. Avicanna Inc. Toronto, CANADA
Avicanna launches its initiative to supply major Canadian hospitals with its advanced RHO Phyto medical cannabis products supported by education, training, and patient support programs.
Seven RHO Phyto products will be available for purchase at Sunnybrook Hospital
’s
Odette Cancer Centre pharmacy by patients that have been issued a written order from an authorized health care practitioner.
The collaborative program is aimed at setting a gold standard for medical cannabis care by establishing a complete cannabis consultation and dosing regimen provided through the expertise of Avicanna’s medical team and the Sunnybrook Hospital pharmacy team.
Avicannaâ or the â
Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce that Avicannaâs Chief Executive Officer, Aras Azadian has been invited to present at
Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC. The conference will take place on March 17 and 18 from 9:00 am-5:00 pm EST featuring roundtable discussions with C-suite executives moderated by Maxim Research Analysts, fireside chats with live Q&A, and presentations from hundreds of issuers both domestically and internationally.
During this virtual conference, Avicanna will present along with other important voices in the cannabis industry. You will also hear from healthcare leaders treating a broad range of indications; cannabis entrepreneurs exploring the changing landscape; tech innovators changing how we work and pl
Avicanna to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Author of the article:
GlobeNewswire
Publishing date: Jan 28, 2021  â¢Â January 28, 2021  â¢Â 7 minute read  â¢Â
Article content
RHO Phyto Deep Tissue Gels will be initially available on the Medical Cannabis by Shoppers Drug Mart⢠online platform and expanded into specific consumer retail channels in February 2021.
Initiation of osteoarthritis preclinical trials in Canada in addition to the enrollment of the products into the UHN MC-RWE study to evaluate the effectiveness on pain, sleep, anxiety, and depression.
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) â Avicanna Inc. (â
Avicannaâ or the â
Companyâ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the launch of the RHO Phyto⢠Deep Tissue Gels (the â
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Avicanna Initiates Pre-Clinical and Behavioural Studies on its RHO Phyto™ Formulary with .
Avicanna Inc.January 21, 2021 GMT
TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) Avicanna Inc. (“Avicanna” or the “Company“) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products has updated and amended its collaboration with Dr. Jibran Khokhar, Assistant Professor at the University of Guelph, and initiated prioritized pre-clinical studies on the RHO Phyto formulations that are commercialized in Canada and Colombia. Additionally, the Company provides an update on research projects with the University of Toronto and Thompson Rivers University as well as a change to its management team.